E P Krenning

Octreotide scintigraphy in thyroidal and orbital Graves' disease.

W M Wiersinga, M N Gerding, M F Prummel, 1998, Thyroid : official journal of the American Thyroid Association.

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

E P Krenning, T. Visser, B. Bernard, 1998, Cancer research.

Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity.

E P Krenning, E. Krenning, H. Pols, 1997, The Journal of clinical endocrinology and metabolism.

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

E P Krenning, J C Reubi, T. Visser, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults

E P Krenning, E. Krenning, M. D. de Ridder, 2002, Archives of disease in childhood.

Neuroendocrine tumors and somatostatin: imaging techniques.

E P Krenning, R. Valkema, E. Krenning, 2005, Journal of endocrinological investigation.

Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.

E P Krenning, T. Visser, B. Bernard, 1998, Nuclear medicine communications.

Peptide receptor imaging and therapy.

E P Krenning, E. Krenning, M. de Jong, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.

E P Krenning, E. Krenning, J. Erion, 2001, European journal of nuclear medicine.